Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: A pilot study

Psycho-Oncology

Volumn 23, Issue 6, 2014, Pages 713-715

  Hunter, Aimee M ^a,b   Kwan, Lorna ^c   Ercoli, Linda M ^a   Mills, Barbara Kahn ^c   Cook, Ian A ^a,b   Ganz, Patricia A ^c,d   Leuchter, Andrew F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarker; breast cancer; cognitive complaints; EEG; oncology

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

ADULT; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER SURVIVOR; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COGNITIVE DEFECT; DISEASE MARKER; ELECTRODE; ELECTROENCEPHALOGRAPH; ELECTROENCEPHALOGRAPHY; EYE MOVEMENT; FEMALE; HUMAN; LETTER; PILOT STUDY; RESTING STATE NETWORK; ADJUVANT CHEMORADIOTHERAPY; BRAIN; BREAST NEOPLASMS; COGNITION DISORDERS; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; SURVIVOR;

BIOLOGICAL MARKERS; BRAIN; BREAST NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; PILOT PROJECTS; SURVIVORS;

EID: 84901988675     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3487     Document Type: Letter

References (10)

1. Ganz PA, Kwan L, Castellon SA, et al,. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst 2013; 105 (11): 791-801.
2. Wefel JS, Schagen SB,. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep 2012; 12 (3): 267-275.
3. MacCormick RE,. Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty? Med Hypotheses 2006; 67: 212-215. (Pubitemid 43825607)
4. Ahles TA, Root JC, Ryan EL,. Cancer- and cancer treatment-associated cognitive change: an update on the state of the science. J Clin Oncol 2012; 30 (30): 3675-3686.
5. Babiloni C, Vecchio F, Lizio R, et al,. Resting state cortical rhythms in mild cognitive impairment and Alzheimer's disease: electroencephalographic evidence. J of Alzheimer's Dis 2011; 26 (Suppl 3): 201-214.
6. Ercoli LM, Castellon SA, Hunter AM, et al,. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav 2013; 7: 543-553.
7. Pullens MJJ, De Vries J, Roukema JA,. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 2010; 19: 1127-1138.
8. Liu L, Rissling M, Neikrug A, et al,. Fatigue and circadian activity rhythms in breast cancer patients before and after chemotherapy: a controlled study. Fatigue: Biomed, Health Behav 2012. http://www.researchgate.net/profile/ Michelle-Rissling/publications/. (Accessed 10 July 2013).
9. Hunter AM, Leuchter AF, Morgan ML, et al,. Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology 2005; 30: 792-799. (Pubitemid 40397086)
10. Holschneider DP, Leuchter AF,. Beta activity in aging and dementia. Brain Topography 1995; 8: 169-180.